Form 8-K - Current report:
SEC Accession No. 0001193125-26-228902
Filing Date
2026-05-18
Accepted
2026-05-18 16:06:05
Documents
22
Period of Report
2026-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113366d8k.htm   iXBRL 8-K 45919
2 EX-4.1 d113366dex41.htm EX-4.1 617891
3 EX-99.1 d113366dex991.htm EX-99.1 12581
4 EX-99.2 d113366dex992.htm EX-99.2 15949
8 GRAPHIC g113366dsp003.jpg GRAPHIC 3814
9 GRAPHIC g113366dsp004.jpg GRAPHIC 4489
10 GRAPHIC g113366dsp005.jpg GRAPHIC 4360
11 GRAPHIC g113366dsp006.jpg GRAPHIC 4312
12 GRAPHIC g113366dsp007a.jpg GRAPHIC 3898
13 GRAPHIC g113366dsp007b.jpg GRAPHIC 5903
14 GRAPHIC g113366g0516025805553.jpg GRAPHIC 5199
15 GRAPHIC g113366g0516030134786.jpg GRAPHIC 5106
  Complete submission text file 0001193125-26-228902.txt   997439

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mirm-20260512.xsd EX-101.SCH 3177
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20260512_lab.xml EX-101.LAB 17992
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20260512_pre.xml EX-101.PRE 11259
25 EXTRACTED XBRL INSTANCE DOCUMENT d113366d8k_htm.xml XML 3655
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 26993156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)